Archive - April 2021
New advice on COVID-19 vaccination for pregnant women in UK
EC approves new Sarclisa indication
Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
Alexion and NICE agree confidential discount for Ultomiris use on the NHS
CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
New subcutaneous formulation of Tysabri approved in UK
EMA begins review of GSK/Vir’s COVID-19 antibody